Health

Cold-causing adenovirus used in four experimental COVID-19 vaccines increased risk of HIV infection when used in AIDS vaccine trials

Solidarity fails to find mortality benefits in four treatments—but the global trial itself wins praise

Trisha Greenhalgh argues COVID-19 shows how too much weight on evidence-based medicine can be the enemy of good policy

Ethical dilemmas will abound for efficacy trials that continue after one vaccine proves itself

Approach for Angelman syndrome is at forefront of efforts to treat autism-linked conditions that stem from single genes

Host variants boost severity risk, may point to drug options

New methods could make systematic reviews relevant during health emergencies

CRISPR-based approach is much faster than current diagnostics, but does have some limitations

Meeting seeks to allay fears that Trump will push a vaccine through before Election Day

Primate centers band together for study rejected by Operation Warp Speed

Scientists find relatives of rubella in bats, wild mice, and zoo animals

President was given an antibody cocktail, still being evaluated in clinical trials, that targets a surface protein of the new coronavirus

“Landmark achievement” in battle against viral infections helped protect the blood supply and led to development of effective drugs

In another candid interview, the NIAID director explains how he tries to counters White House optimism with “reality”

“Obviously, the president of the United States has access to everything”

Regeneron’s monoclonal antibody cocktail reduces viral load in people infected with SARS-CoV-2